Effect of cognitive reserve on amnestic mild cognitive impairment due to Alzheimer's disease defined by fluorodeoxyglucose-positron emission tomography
- PMID: 36034127
- PMCID: PMC9399434
- DOI: 10.3389/fnagi.2022.932906
Effect of cognitive reserve on amnestic mild cognitive impairment due to Alzheimer's disease defined by fluorodeoxyglucose-positron emission tomography
Abstract
This study aimed to investigate the effect of cognitive reserve (CR) on the rate of cognitive decline and cerebral glucose metabolism in amnestic mild cognitive impairment (MCI) using the Study on Diagnosis of Early Alzheimer's Disease-Japan (SEAD-J) dataset. The patients in SEAD-J underwent cognitive tests and fluorodeoxyglucose-positron emission tomography (FDG-PET). MCI to be studied was classified as amnestic MCI due to Alzheimer's disease (AD) with neurodegeneration. A total of 57 patients were visually interpreted as having an AD pattern (P1 pattern, Silverman's classification). The 57 individuals showing the P1 pattern were divided into a high-education group (years of school education ≥13, N = 18) and a low-education group (years of school education ≤12, N = 39). Voxel-based statistical parametric mapping revealed more severe hypometabolism in the high-education group than in the low-education group. Glucose metabolism in the hippocampus and temporoparietal area was inversely associated with the years of school education in the high- and low-education groups (N = 57). General linear mixed model analyses demonstrated that cognitive decline was more rapid in the high-education group during 3-year follow-up. These results suggest that the cerebral glucose metabolism is lower and cognitive function declines faster in patients with high CR of amnestic MCI due to AD defined by FDG-PET.
Keywords: Alzheimer’s disease (AD); cerebral glucose metabolism; cognitive reserve; education; mild cognitive impairment.
Copyright © 2022 Kato, Nishita, Otsuka, Inui, Nakamura, Kimura, Ito and SEAD-J Study Group.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).Alzheimers Res Ther. 2018 Apr 3;10(1):35. doi: 10.1186/s13195-018-0366-y. Alzheimers Res Ther. 2018. PMID: 29615111 Free PMC article.
-
Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.J Alzheimers Dis. 2016 Apr 12;52(4):1385-401. doi: 10.3233/JAD-160145. J Alzheimers Dis. 2016. PMID: 27079727
-
Functional neuroimaging using F-18 FDG PET/CT in amnestic mild cognitive impairment: A preliminary study.Indian J Nucl Med. 2013 Jul;28(3):129-33. doi: 10.4103/0972-3919.119538. Indian J Nucl Med. 2013. PMID: 24250019 Free PMC article.
-
Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer's dementia: a meta-analysis.Transl Neurodegener. 2018 Apr 23;7:9. doi: 10.1186/s40035-018-0114-z. eCollection 2018. Transl Neurodegener. 2018. PMID: 29713467 Free PMC article. Review.
-
Brain fluorodeoxyglucose (FDG) PET in dementia.Ageing Res Rev. 2016 Sep;30:73-84. doi: 10.1016/j.arr.2016.02.003. Epub 2016 Feb 11. Ageing Res Rev. 2016. PMID: 26876244 Review.
References
-
- Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7 270–279. 10.1016/j.jalz.2011.03.008 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
